Cheng‐Long Xu, Li‐Hua Zhao, Jun Tang, Xian‐Heng Song, Zhe Dou, Ya‐Jun Wang
{"title":"Structure‐Guided Engineering of Alcohol Dehydrogenase for the Stereodivergent Synthesis of Amino Alcohols via Desymmetrization of Cyclic Diketones","authors":"Cheng‐Long Xu, Li‐Hua Zhao, Jun Tang, Xian‐Heng Song, Zhe Dou, Ya‐Jun Wang","doi":"10.1002/bit.70183","DOIUrl":null,"url":null,"abstract":"Chiral cyclic vicinal amino alcohols constitute essential structural motifs in numerous pharmaceutical agents, yet their asymmetric synthesis from readily available symmetric precursors remains a formidable challenge due to difficulties in controlling stereochemistry and preventing over‐reduction. Herein, we report a stereodivergent, one‐pot dual‐enzyme cascade that successfully overcomes these limitations to access all four stereoisomers of 2‐aminocyclohexanol from 1,2‐cyclohexanedione. Central to this strategy is the development of a “rudder” model‐guided protein engineering approach, which reshaped the active site of <jats:italic>Lactobacillus kefiri</jats:italic> alcohol dehydrogenase ( <jats:italic>Lk</jats:italic> ADH). This rational design yielded two key mutants, A145Q/G195L and I144Y/G195N, which exhibit exquisite stereocomplementary control over the critical monoreduction step. When coupled with stereoselective amine transaminases, this cascade operates with exceptional efficiency, delivering the target amino alcohols with yields up to 99% and excellent optical purity (> 99% <jats:italic>ee</jats:italic> and up to 99% <jats:italic>de</jats:italic> ). This methodology not only provides a robust platform for the high‐atom‐economy synthesis of high‐value chiral building blocks but also demonstrates the power of structure‐based enzyme redesign in solving complex synthetic problems.","PeriodicalId":9168,"journal":{"name":"Biotechnology and Bioengineering","volume":"188 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology and Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/bit.70183","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Chiral cyclic vicinal amino alcohols constitute essential structural motifs in numerous pharmaceutical agents, yet their asymmetric synthesis from readily available symmetric precursors remains a formidable challenge due to difficulties in controlling stereochemistry and preventing over‐reduction. Herein, we report a stereodivergent, one‐pot dual‐enzyme cascade that successfully overcomes these limitations to access all four stereoisomers of 2‐aminocyclohexanol from 1,2‐cyclohexanedione. Central to this strategy is the development of a “rudder” model‐guided protein engineering approach, which reshaped the active site of Lactobacillus kefiri alcohol dehydrogenase ( Lk ADH). This rational design yielded two key mutants, A145Q/G195L and I144Y/G195N, which exhibit exquisite stereocomplementary control over the critical monoreduction step. When coupled with stereoselective amine transaminases, this cascade operates with exceptional efficiency, delivering the target amino alcohols with yields up to 99% and excellent optical purity (> 99% ee and up to 99% de ). This methodology not only provides a robust platform for the high‐atom‐economy synthesis of high‐value chiral building blocks but also demonstrates the power of structure‐based enzyme redesign in solving complex synthetic problems.
期刊介绍:
Biotechnology & Bioengineering publishes Perspectives, Articles, Reviews, Mini-Reviews, and Communications to the Editor that embrace all aspects of biotechnology. These include:
-Enzyme systems and their applications, including enzyme reactors, purification, and applied aspects of protein engineering
-Animal-cell biotechnology, including media development
-Applied aspects of cellular physiology, metabolism, and energetics
-Biocatalysis and applied enzymology, including enzyme reactors, protein engineering, and nanobiotechnology
-Biothermodynamics
-Biofuels, including biomass and renewable resource engineering
-Biomaterials, including delivery systems and materials for tissue engineering
-Bioprocess engineering, including kinetics and modeling of biological systems, transport phenomena in bioreactors, bioreactor design, monitoring, and control
-Biosensors and instrumentation
-Computational and systems biology, including bioinformatics and genomic/proteomic studies
-Environmental biotechnology, including biofilms, algal systems, and bioremediation
-Metabolic and cellular engineering
-Plant-cell biotechnology
-Spectroscopic and other analytical techniques for biotechnological applications
-Synthetic biology
-Tissue engineering, stem-cell bioengineering, regenerative medicine, gene therapy and delivery systems
The editors will consider papers for publication based on novelty, their immediate or future impact on biotechnological processes, and their contribution to the advancement of biochemical engineering science. Submission of papers dealing with routine aspects of bioprocessing, description of established equipment, and routine applications of established methodologies (e.g., control strategies, modeling, experimental methods) is discouraged. Theoretical papers will be judged based on the novelty of the approach and their potential impact, or on their novel capability to predict and elucidate experimental observations.